Cypress Pharmaceutical Receives FDA Approval of Cetirizine Hydrochloride Oral Solution

Published: Oct 15, 2008

MADISON, Miss.--(BUSINESS WIRE)--Cypress Pharmaceutical, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted final approval of the company’s abbreviated new drug application (ANDA) for the prescription and over-the-counter versions of Cetirizine Hydrochloride Oral Solution, 1 mg/1 mL.

Back to news